175 related articles for article (PubMed ID: 38341456)
1. The effects of OPRM1 118A>G on methadone response in pain management in advanced cancer at end of life.
Haupt LM; Haywood A; Sutherland HG; Yu C; Albury CL; Pharasi A; Zunk M; George R; Griffiths LR; Good P; Hardy J
Sci Rep; 2024 Feb; 14(1):3411. PubMed ID: 38341456
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the Effects of OPRM1 A118G Polymorphism Using Different Opioids: A Prospective Study.
Takemura M; Niki K; Okamoto Y; Kawamura T; Kohno M; Matsuda Y; Ikeda K
J Pain Symptom Manage; 2024 Jan; 67(1):39-49.e5. PubMed ID: 37757956
[TBL] [Abstract][Full Text] [Related]
3. Association of polymorphisms in
Ozberk D; Haywood A; Sutherland HG; Yu C; Albury CL; Zunk M; George R; Good P; Griffiths LR; Hardy J; Haupt LM
Pharmacogenomics; 2022 Apr; 23(5):281-289. PubMed ID: 35189719
[No Abstract] [Full Text] [Related]
4. Effects of the OPRM1 A118G Polymorphism (rs1799971) on Opioid Analgesia in Cancer Pain: A Systematic Review and Meta-Analysis.
Yu Z; Wen L; Shen X; Zhang H
Clin J Pain; 2019 Jan; 35(1):77-86. PubMed ID: 30028366
[TBL] [Abstract][Full Text] [Related]
5. The role of hydromorphone and OPRM1 in postoperative pain relief with hydrocodone.
Boswell MV; Stauble ME; Loyd GE; Langman L; Ramey-Hartung B; Baumgartner RN; Tucker WW; Jortani SA
Pain Physician; 2013; 16(3):E227-35. PubMed ID: 23703421
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide association study of therapeutic opioid dosing identifies a novel locus upstream of OPRM1.
Smith AH; Jensen KP; Li J; Nunez Y; Farrer LA; Hakonarson H; Cook-Sather SD; Kranzler HR; Gelernter J
Mol Psychiatry; 2017 Mar; 22(3):346-352. PubMed ID: 28115739
[TBL] [Abstract][Full Text] [Related]
7. Gene polymorphisms of OPRM1 A118G and ABCB1 C3435T may influence opioid requirements in Chinese patients with cancer pain.
Gong XD; Wang JY; Liu F; Yuan HH; Zhang WY; Guo YH; Jiang B
Asian Pac J Cancer Prev; 2013; 14(5):2937-43. PubMed ID: 23803057
[TBL] [Abstract][Full Text] [Related]
8. OPRM1 c.118A>G Polymorphism and Duration of Morphine Treatment Associated with Morphine Doses and Quality-of-Life in Palliative Cancer Pain Settings.
Hajj A; Halepian L; Osta NE; Chahine G; Kattan J; Rabbaa Khabbaz L
Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28346387
[TBL] [Abstract][Full Text] [Related]
9. The Relevance of the OPRM1 118A>G Genetic Variant for Opioid Requirement in Pain Treatment: A Meta-Analysis.
Zhang X; Liang Y; Zhang N; Yan Y; Liu S; Fengxi H; Zhao D; Chu H
Pain Physician; 2019 Jul; 22(4):331-340. PubMed ID: 31337162
[TBL] [Abstract][Full Text] [Related]
10. Association of KCNJ6 rs2070995 and methadone response for pain management in advanced cancer at end-of-life.
Ozberk D; Haywood A; Sutherland HG; Yu C; Albury CL; Zunk M; George R; Good P; Griffiths LR; Hardy J; Haupt LM
Sci Rep; 2022 Oct; 12(1):17422. PubMed ID: 36261449
[TBL] [Abstract][Full Text] [Related]
11. Micro opioid receptor A118G polymorphism and post-operative pain: opioids' effects on heterozygous patients.
De Capraris A; Cinnella G; Marolla A; Salatto P; Da Lima S; Vetuschi P; Consoletti L; Gesualdo L; Dambrosio M
Int J Immunopathol Pharmacol; 2011; 24(4):993-1004. PubMed ID: 22230405
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of the relevance of the OPRM1 118A>G genetic variant for pain treatment.
Walter C; Lötsch J
Pain; 2009 Dec; 146(3):270-275. PubMed ID: 19683391
[TBL] [Abstract][Full Text] [Related]
13. Allele frequency and genotype distribution of the opioid receptor μ-1 (OPRM1) A118G polymorphism in the Western Saudi population.
Bagher AM; Hareeri RH
J Appl Biomed; 2023 Sep; 21(3):160-165. PubMed ID: 37747315
[TBL] [Abstract][Full Text] [Related]
14. [Relationship of OPRM1 118A/G gene polymorphism and oxycodone analygesic dose in paitents with cancer pain].
Lin T; Li X; Song J; Zhang C; Bie M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Dec; 35(6):887-890. PubMed ID: 30512171
[TBL] [Abstract][Full Text] [Related]
15. Pain polymorphisms and opioids: An evidence based review.
Vieira CMP; Fragoso RM; Pereira D; Medeiros R
Mol Med Rep; 2019 Mar; 19(3):1423-1434. PubMed ID: 30592275
[TBL] [Abstract][Full Text] [Related]
16. CYP2B6 and OPRM1 Receptor Polymorphisms at Methadone Clinics And Novel OPRM1 Haplotypes: A Cross-Sectional Study.
AlMeman AA; Ismail R; Perola M
Drug Metab Lett; 2016; 10(3):213-218. PubMed ID: 27515451
[TBL] [Abstract][Full Text] [Related]
17. Haplotype-Based Association and In Silico Studies of OPRM1 Gene Variants with Susceptibility to Opioid Dependence Among Addicted Iranians Undergoing Methadone Treatment.
Tolami HF; Sharafshah A; Tolami LF; Keshavarz P
J Mol Neurosci; 2020 Apr; 70(4):504-513. PubMed ID: 31853823
[TBL] [Abstract][Full Text] [Related]
18. The Influence of OPRM1 A118G Polymorphism on the Dosage of Morphine in Patients with Advanced Liver Cancer.
Cheng H; Chu X; Yi S
J Coll Physicians Surg Pak; 2021 Nov; 31(11):1375-1377. PubMed ID: 34689504
[TBL] [Abstract][Full Text] [Related]
19. Association between rs1799971 in the mu opioid receptor gene and methadone maintenance treatment response.
Xie X; Gu J; Zhuang D; Zhou Y; Chen X; Shen W; Li L; Liu Y; Xu W; Hong Q; Xu Z; Chen W; Zhou W; Liu H
J Clin Lab Anal; 2022 Nov; 36(11):e24750. PubMed ID: 36305091
[TBL] [Abstract][Full Text] [Related]
20. The role of methadone in cancer-induced bone pain: a retrospective cohort study.
Sulistio M; Wojnar R; Key S; Kwok J; Al-Rubaie Z; Michael N
Support Care Cancer; 2021 Mar; 29(3):1327-1335. PubMed ID: 32627056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
